Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract for National Institute of Neurological Disorders and Stroke

Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract for National Institute of Neurological Disorders and Stroke

Wesley Vestal Named CAI's Chief People Officer; Joins Company Leadership Team

Wesley Vestal Named CAI's Chief People Officer; Joins Company Leadership Team

Molecular Devices and Advanced Solutions Life Sciences collaborate to develop 3D Biology Automation Technologies for Drug Discovery

Molecular Devices, a leader in high-performance life sciences solutions, on Wednesday announced a new collaboration with Advanced Solutions, a biofabrication and life sciences robotics company. This new collaboration takes the form of a turnkey solution that systematically bioprints organoids in a fully-automated enclosure, with award-winning high-content imaging capabilities that inform the modeling and screening process for increased precision--enabling the industry to grow, screen, and analyze high-quality, viable, 3D cell cultures at scale.

CD BioSciences Introduces Various Solutions for Autophagic Cell Death Studies

CD BioSciences recently launched another comprehensive panel of research solutions for autophagic cell death studies.

Creative Diagnostics Introduces New Hemagglutination Inhibition Assay Services

Creative Diagnostics recently introduced Hemagglutination Inhibition Assay services to determine relative concentrations of viruses, bacteria, or antibodies.

STEMart Introduces API Impurity Identification Services for Medical Devices

STEMart has recently introduced API Impurity Identification services for global clients.

OncoDxRx Honing Unique Transformative Technologies for Personalized Diagnostic Capability

OncoDxRx's unique liquid biopsy technologies create another dimension beyond traditional diagnostic capability.

Abzena hires Matthew Stober to lead the company through the next phase of global growth

Matthew Stober hired as CEO and joins Abzena Board. Abzena continues growth as the leading provider of development and manufacturing services for Antibody Drug Conjugate (ADC) and complex biologics. Board enhanced with CDMO and Biologics industry luminaries to support future growth.

Verana Health and Sight Sciences Collaborate on Glaucoma Research Using Curated Real-World Data from the IRIS Registry

Verana Health and Sight Sciences Collaborate on Glaucoma Research Using Curated Real-World Data from the IRIS Registry

Blue Spark Technologies to Highlight Continuous Patient Temperature Monitoring at CES 2023

Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, will showcase TempTraq® at the 2023 Consumer Electronics Show (CES) at the Las Vegas Convention Center January 5-8.

OncoDxRx Demonstrating the Power of Its One-Of-A-Kind RNA Technologies to Go Beyond Diagnostics

OncoDxRx will thus secure its forefront position to deal with cancer patients in all stages, whether in the context of cancer screening and prevention or in the context of treatment selection, recurrence monitoring or drug discovery.

Creative Biogene Has Established More Than 50 Engineered Zebrafish Models to Support Human Cancer Research

Microbiosci Develops Microbial Cell Line Generation for Therapeutics and Diagnostic Applications

Creative Biogene Has Developed GMP Lentivirus Production Service to Accelerate Cell Therapy and Gene Therapy

Histobiolab Releases Over 150 FISH Probes for Hematology, Pathology and Constitutional Cytogenetics

Acroscell Provides Customized Ionic Channel Expression System to Satisfy Screening Needs

Creative Bioarray Develops Cell Culture Media Solutions for Biological and Pharmaceutical Research

CD ComputaBio Releases AutoDock Vina Software to Accelerate Molecular Docking Projects

FDA Approved ALK Inhibitors for ALK-Positive Non-Small Cell Lung Cancer

Atom Transfer Radical Polymerization (ATRP)